Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial (Q40875359)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial |
scientific article |
Statements
1 reference
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial (English)
1 reference
1 reference
1 reference
Dirk Schadendorf
1 reference
Keith Flaherty
1 reference
Antoni Ribas
1 reference
Axel Hauschild
1 reference
Jhangir G Irani
1 reference
Nadezhda Kovalenko
1 reference
Claus Garbe
1 reference
Celeste Lebbe
1 reference
Jeffrey J Legos
1 reference
Douglas J DeMarini
1 reference
Thomas Jouary
1 reference
Bijoyesh Mookerjee
1 reference
Helen Gogas
1 reference
John B A G Haanen
1 reference
James Larkin
1 reference
Vanna Chiarion-Sileni
1 reference
Mario MandalÃ
1 reference
Michael Millward
1 reference
Johan Hansson
1 reference
Peter Mohr
1 reference
Volodymr Probachai
1 reference
Paul Nathan
1 reference
Suzanne Swann
1 reference
Fan Jin
1 reference
31 May 2015
1 reference
1 reference
Identifiers
1 reference